Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China
NCT00952367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3641
Last updated 2012-04-23
Summary
This study is to observe the carriage rate of Streptococcus pneumoniae (S.p.), Haemophilus influenzae Type B (Hib) and Moraxella catarrhalis (M.Cat.) in healthy Chinese children aged 12-18 months in order to estimate the prevalence of pathogens that commonly cause infection in Chinese young children. The antibiotic resistance of all isolates and the serotypes distribution of S.p. isolates will also be tested. Potential risk factors for nasopharyngeal carriage will be collected.
Conditions
- Streptococcus Pneumoniae Infections
Interventions
- OTHER
-
Nasopharyngeal swab
Nasopharyngeal swab
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 12 Months
- Max Age
- 18 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- China
Study Locations
More Related Trials
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects
NCT01531322 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®
NCT00488371 ·Status: COMPLETED
-
A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS
NCT05372575 ·Status: COMPLETED ·Phase: NA
-
Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate Vaccine
NCT05939219 ·Status: UNKNOWN ·Phase: NA
-
Nasopharyngeal Carriage of S. Pneumoniae
NCT04460313 ·Status: RECRUITING ·Phase: NA
-
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT05092386 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Pneumococcal Carriage in RSV Bronchiolitis in Infants Aged 6 to 18 Months
NCT06722716 ·Status: NOT_YET_RECRUITING
-
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria
NCT01193582 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
NCT00195611 ·Status: COMPLETED
-
A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant
NCT07023081 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China
NCT01692886 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children
NCT01545375 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
NCT04357522 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants
NCT01262872 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
NCT07035054 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months
NCT04108845 ·Status: UNKNOWN ·Phase: PHASE1
-
Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)
NCT02736240 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years
NCT06210737 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months
NCT01425372 ·Status: COMPLETED
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants
NCT00574795 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence and Serotype Distribution of Streptococcus Pneumoniae in Healthy Vietnamese Children From 6 Months to 5 Years Old
NCT06638333 ·Status: ACTIVE_NOT_RECRUITING
-
Study Evaluating 7-Valent Pneumococcal Conjugate Vaccine in Healthy Infants
NCT00488826 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
NCT04100772 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
NCT05759520 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of wSp Vaccine in Young Children
NCT07216430 ·Status: RECRUITING ·Phase: PHASE2